Reactive angioendotheliomatosis revealing a glomerulopathy secondary to a monoclonal gammopathy successfully treated with lenalidomide

J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e115-e118. doi: 10.1111/jdv.16840. Epub 2020 Aug 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Hemangioendothelioma*
  • Humans
  • Lenalidomide / therapeutic use
  • Paraproteinemias* / complications
  • Paraproteinemias* / drug therapy
  • Skin Neoplasms*

Substances

  • Lenalidomide

Supplementary concepts

  • Reactive angioendotheliomatosis